Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Thorsten Nitsch
Observed names:
T Nitsch,
T. Nitsch
Institution:
Klinikum Passau
Observed institutions:
University of Bremen,
Humboldt-Universität zu Berlin,
Düsseldorf University Hospital,
Westpfalz Klinikum,
Francis Hospital,
Klinikum Passau,
Heinrich Heine University Düsseldorf,
Charité – Universitätsmedizin Berlin
show all 8
OpenAlex ID:
A5044858298
Up-Front Tandem High-Dose Chemotherapy Compared With Standard Chemotherapy With Doxorubicin and Paclitaxel in Metastatic Breast Cancer: Results of a Randomized Trial
2005
·
Peter Schmid
, Walter Schippinger
, et al.
·
Journal of Clinical Oncology
·
64
Acquisition of TGF-beta 1 resistance: an important progression factor in human renal cell carcinoma.
1997
·
U Ramp
, K Jaquet
, et al.
·
PubMed
·
39
Functional Intactness of Stimulatory and Inhibitory Autocrine Loops in Human Renal Carcinoma Cell Lines of the Clear Cell Type
1997
·
Uwe Ramp
, Kai Jaquet
, et al.
·
The Journal of Urology
·
38
Analysis of growth factor-dependent signalling in human epithelioid sarcoma cell lines
2000
·
C.-D. Gerharz
, U. Ramp
, et al.
·
European Journal of Cancer
·
13
Acquisition of TGF-beta 1 Resistance: An Important Progression Factor in Human Renal Cell Carcinoma
1998
·
U. Ramp
, K. Jaquet
, et al.
·
The Journal of Urology
·
6
Up front tandem high-dose chemotherapy (HD) compared to standard chemotherapy with doxorubicin and paclitaxel (AT) in metastatic breast cancer (MBC): Final results of a randomized trial
2004
·
P. Schmid
, W. Schippinger
, et al.
·
Journal of Clinical Oncology
·
5
Fieber, Vorhofflimmern und Angina pectoris bei einem 58-jährigen Patienten
2014
·
M. Groebner
, T. Südhoff
, et al.
·
Der Internist
·
2
Acquisition of TGF-beta 1 Resistance: An Important Progression Factor in Human Renal Cell Carcinoma
1998
·
U. Ramp
, K. Jaquet
, et al.
·
The Journal of Urology
·
1
TGF-ß1 resistance as a major progression factor in human renal cell carcinoma
1997
·
U. Ramp
, K. Jaquet
, et al.
·
European Journal of Cancer
·
1
Ex vivo drug testing in metastatic biopsies reveals patient-specific vulnerabilities to cancer targeting and immune activating drugs
2026
·
Lukas Wöhrl
, Durdam Das
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
PDF
Ultrasound guided biopsy of osteolytic bone lesions
2023
·
Thorsten Nitsch
, Julia Lanznaster
, et al.
·
Ultraschall in der Medizin - European Journal of Ultrasound
Ultrasound guided biopsy of the mediastinum
2023
·
Thorsten Nitsch
, Julia Lanznaster
, et al.
·
Ultraschall in der Medizin - European Journal of Ultrasound
Ultrasound guided biopsy in hematology and oncology
2023
·
Thorsten Nitsch
, Julia Lanznaster
, et al.
·
Ultraschall in der Medizin - European Journal of Ultrasound
Ultraschall gesteuerte Biopsie des Mediastinums
2022
·
Thorsten Nitsch
, Julia Lanznaster
, et al.
·
Ultraschall in der Medizin - European Journal of Ultrasound
Ultraschall gesteuerte Lymphkontenbiopsie
2019
·
T Nitsch
, T Südhoff
·
Ultraschall in der Medizin - European Journal of Ultrasound
Ultraschall gesteuerte Biopsie bei onkologischen Patienten
2019
·
T Nitsch
, T Südhoff
·
Ultraschall in der Medizin - European Journal of Ultrasound
Ultraschall gesteuerte Biopsie von osteolytischen Knochenläsionen
2017
·
T Nitsch
, C Schicht
, et al.
·
Ultraschall in der Medizin - European Journal of Ultrasound
Human chromophobe renal cell carcinoma: Establishment and molecular characterization of two permanent cell lines
1995
·
U. Ramp
, C. D. Gerharz
, et al.
·
Journal of Cancer Research and Clinical Oncology
Show more works
View as search
Works count:
18
Citation count:
169
H-index:
5
I10-index:
4
Year
Topic
Type